Porter Stuart D 4

What Happened

• Stuart D. Porter, a director of Lixte Biotechnology Holdings, Inc. (LIXT), received a grant of 25,000 restricted share units (RSUs) on 2026-05-29. The grant price is reported as $0.00 (award), so there was no cash purchase or sale in this transaction. Each RSU is a contingent right to one share of common stock upon vesting.

Key Details

• Transaction date: May 29, 2026; Form 4 filed June 1, 2026 (timely filing).
• Grant size and price: 25,000 RSUs at $0.00 (award/grant).
• Vesting: 25% vested on May 29, 2026, then 25% on the last date of each subsequent calendar quarter until fully vested.
• Plan: Granted under the Lixte Biotechnology Holdings, Inc. 2020 Stock Incentive Plan.
• Shares owned after transaction: not specified in the provided filing.
• Transaction type: Award/Grant (not a purchase or sale).

Context

• RSUs are a contingent right to receive shares upon vesting and subject to continued service; they do not represent immediate ownership of shares or a cash investment by the insider. Such awards are routine compensation for directors/executives and do not by themselves indicate a buying or selling signal. The eventual value depends on LIXT’s stock price at each vesting date.